The Westland location offers a full spectrum of diagnostic and therapeutic services, including EEG and EMG testing, alongside specialized infusion therapies for conditions such as multiple sclerosis, Alzheimer’s, and various neuromuscular disorders. By decentralizing these services from large hospital systems, the practice intends to streamline care for an aging population facing a rising prevalence of neurological health challenges throughout Southeast Michigan.

Dr. Daniel Singer, a board-certified neurologist at MIND, emphasized that the expansion addresses a critical need for consistent, coordinated treatment. The new center will operate in conjunction with the organization’s flagship Farmington Hills campus, effectively replacing the current Dearborn Heights site to consolidate resources. This move integrates regional patient care with the broader subspecialist network, providing local residents with advanced clinical research and specialized diagnostic tools without the necessity of traveling to major metropolitan hubs.